A Phase IV Pilot Study on Optimizing the Treatment in HBeAg Positive CHB Patients With Response Guide Treatment (RGT) Method.

Trial Profile

A Phase IV Pilot Study on Optimizing the Treatment in HBeAg Positive CHB Patients With Response Guide Treatment (RGT) Method.

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 May 2016

At a glance

  • Drugs Peginterferon alfa-2a (Primary) ; Adefovir
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 26 May 2016 Primary endpoint has not been met. (Change of quantitative HBsAg from baseline to EOF), as per results published in the Journal of Hepatology.
    • 26 May 2016 Results published in the Journal of Hepatology
    • 31 Mar 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top